Escalquens, France

Frédéric Cosledan

This inventor holds 1 USPTO granted patent. Top assignee: Eukarion, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frédéric Cosledan. Retrieved from https://idiyas.com/inventor/frandeacutedandeacuteric-cosledan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frédéric Cosledan: Innovator in Non-Genotoxic Metalloporphyrins

Introduction

Frédéric Cosledan is a notable inventor based in Escalquens, France. He has made significant contributions to the field of chemistry, particularly in the development of non-genotoxic metalloporphyrins. His work focuses on creating synthetic catalytic scavengers that target reactive oxygen species, which are known to contribute to various diseases.

Latest Patents

Frédéric Cosledan holds a patent for his invention titled "Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species." This invention pertains to compounds that are designed to be non-genotoxic and serve as effective scavengers of reactive oxygen chemical species. The patent also covers pharmaceutical compositions that incorporate these compounds and outlines methods for their use in preventing or treating free radical-associated diseases or conditions.

Career Highlights

Frédéric Cosledan has established himself as a key figure in his field through his innovative research and development efforts. His work has the potential to impact the pharmaceutical industry significantly, particularly in the area of disease prevention and treatment.

Collaborations

Frédéric collaborates with Bernard Meunier, contributing to the advancement of their shared research goals. Their partnership enhances the scope and impact of their work in the field of chemistry.

Conclusion

Frédéric Cosledan's contributions to the development of non-genotoxic metalloporphyrins highlight his innovative spirit and dedication to advancing scientific knowledge. His work promises to play a crucial role in addressing health challenges associated with free radicals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…